NMZ-37854-93458
1 vaccination
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 670 / KS
- Registered
- 2021-09-17
- Relationship
- Adult relative or friend
- Guardian
- VFS-31363-78472
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-17
Registered in v-safe
-
2021-09-17
Dose 1 — Janssen/Johnson & Johnson
-
2021-09-17
Health check-in — day 0, dose 1, dependentFeeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-09-18
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain, Itching · HeadacheAdult check-in
- 2021-09-19
- 2021-09-20
- 2021-09-21
-
2021-09-22
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore ThroatMedDRA releases: 2024-11 · check-in free text available
- 2021-09-23
- 2021-09-26
- 2021-10-01
- 2021-12-17
- 2022-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-17 | Janssen/Johnson & Johnson | No |
Free text
Release 9 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Sore Throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release